The Latest Breaking News from PFE

Easing inflation and the Fed’s indication of slowing the pace of interest rate hikes are raising investors’ sentiments. Moreover, the November job report came in better than expected. While uncertainties remain, we think quality stocks Pfizer (PFE), AstraZeneca PLC (AZN), Carrier Global (CARR), J. Jill (JILL), and Lifeway Foods (LWAY)…

Despite rampant market volatility ahead of the November jobs data, and possible recession fears, experts believe the U.S. economy is resilient enough to handle a potential growth slowdown. Given the possibility of a year-end rally, quality stocks Pfizer (PFE) and AT&T (T) could now be ideal additions to your portfolio.…

With the October inflation report showing signs of cooling and anticipations of a slowdown in interest rate hikes, the stock market looks poised to extend its recent rally. Hence, it could be wise to invest in fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and Raytheon Technologies (RTX) that still…

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

The pharmaceutical industry is rapidly evolving to meet today’s health challenges. The pharmaceutical industry's long-term prospects look bright with a globally aging population set to increase healthcare expenditure. Moreover, given the industry’s ability to stay resilient amid economic headwinds, it could be wise to invest in fundamentally strong pharmaceutical stocks…

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

While market volatility is still prevalent, experts believe the U.S. economy might succeed in achieving a 'soft landing.' Moreover, most S&P 500 companies surpassed revenue and EPS estimates in the third quarter. Therefore, fundamentally sound stocks Pfizer (PFE) and Flowers Foods (FLO) could be ideal additions to your portfolio now.…

Although inflation eased slightly last month, the Fed has indicated that the final level of interest rates could be higher than expected. With further interest rate hikes and the possibility of a recession expected to keep the market under pressure, it could be wise to buy dividend-paying stocks Pfizer (PFE),…

Leading biopharmaceutical company Pfizer’s (PFE) third-quarter results demonstrated strength across most areas of its business. Moreover, the company raised its 2022 financial guidance for revenues and adjusted EPS. Also, the company has increased its dividend for 12 consecutive years, and its annual dividend yields more than 3%. Given its solid…

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

The Fed’s aggressive rate hikes to tame the stubborn inflation have led to widespread recession fears. The stock market has witnessed a significant selloff. Moreover, as the bear market seems not over yet, we think fundamentally strong dividend-paying stocks, Pfizer (PFE) and Kroger (KR), might help you beat the bear…